Chemoradiotherapy with twice-weekly administration of low-dose gemcitabine for locally advanced pancreatic cancer

Figure 1 Overall survival curve and progression-free survival curve for 15 patients who received chemoradiotherapy under this study protocol. Dot indicates censored cases.

Figure 2 Overall survival curve for patients with tumor markers reducing more than 50% compared to that of pretreatment (n = 12) and those reducing below 50% (n = 3). Dot indicates censored cases.

Figure 3 Progression free-survival curve for patients with tumor size less than 4-cm (n = 6) and those with a size above 4-cm (n = 9). Dot indicates censored cases.